Local microRNA delivery targets Palladin and prevents metastatic breast cancer

Metastasis is the primary cause for mortality in breast cancer. MicroRNAs, gene expression master regulators, constitute an attractive candidate to control metastasis. Here we show that breast cancer metastasis can be prevented by miR-96 or miR-182 treatment, and decipher the mechanism of action. We found that miR-96/miR-182 downregulate Palladin protein levels, thereby reducing breast cancer cell migration and invasion. A common SNP, rs1071738, at the miR-96/miR-182-binding site within the Palladin 3′-UTR abolishes miRNA:mRNA binding, thus diminishing Palladin regulation by these miRNAs. Regulation is successfully restored by applying complimentary miRNAs. A hydrogel-embedded, gold-nanoparticle-based delivery vehicle provides efficient local, selective, and sustained release of miR-96/miR-182, markedly suppressing metastasis in a breast cancer mouse model. Combined delivery of the miRNAs with a chemotherapy drug, cisplatin, enables significant primary tumour shrinkage and metastasis prevention. Our data corroborate the role of miRNAs in metastasis, and suggest miR-96/miR-182 delivery as a potential anti-metastatic drug.

[1]  Jeffrey K. Mito,et al.  MicroRNA-182 drives metastasis of primary sarcomas by targeting multiple genes. , 2014, The Journal of clinical investigation.

[2]  Álvaro Somoza,et al.  Synthesis and surface modification of uniform MFe2O4 (M = Fe, Mn, and Co) nanoparticles with tunable sizes and functionalities , 2012, Journal of Nanoparticle Research.

[3]  Jar-Yi Ho,et al.  OncomiR miR‐96 and miR‐182 promote cell proliferation and invasion through targeting ephrinA5 in hepatocellular carcinoma , 2016, Molecular carcinogenesis.

[4]  Mariette Schrier,et al.  A Genetic Screen Implicates miRNA-372 and miRNA-373 As Oncogenes in Testicular Germ Cell Tumors , 2006, Cell.

[5]  Steven J. M. Jones,et al.  Comprehensive molecular portraits of human breast tumours , 2013 .

[6]  F. Slack,et al.  A SNP in a let-7 microRNA complementary site in the KRAS 3' untranslated region increases non-small cell lung cancer risk. , 2008, Cancer research.

[7]  Hao-Ven Wang,et al.  Comparative expression analysis of the murine palladin isoforms , 2008, Developmental dynamics : an official publication of the American Association of Anatomists.

[8]  D. Redelman,et al.  The mouse mammary carcinoma 4T1: characterization of the cellular landscape of primary tumours and metastatic tumour foci , 2007, International journal of experimental pathology.

[9]  Stephen Pulman,et al.  Building the Framework , 1996 .

[10]  G. Sledge,et al.  Cisplatin as first-line therapy for metastatic breast cancer. , 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  S. Alahari,et al.  miRNA control of tumor cell invasion and metastasis , 2010, International journal of cancer.

[12]  M. Parast,et al.  Characterization of Palladin, a Novel Protein Localized to Stress Fibers and Cell Adhesions , 2000, The Journal of cell biology.

[13]  N. Dubrawsky.  Cancer statistics , 1989, CA: a cancer journal for clinicians.

[14]  K. Devarajan,et al.  Elevated Expression of Stromal Palladin Predicts Poor Clinical Outcome in Renal Cell Carcinoma , 2011, PloS one.

[15]  K. Lehti,et al.  Actin-associated protein palladin promotes tumor cell invasion by linking extracellular matrix degradation to cell cytoskeleton , 2014, Molecular biology of the cell.

[16]  C. Otey,et al.  Identification of palladin isoforms and characterization of an isoform-specific interaction between Lasp-1 and palladin , 2006, Journal of Cell Science.

[17]  C. Burge,et al.  Conserved Seed Pairing, Often Flanked by Adenosines, Indicates that Thousands of Human Genes are MicroRNA Targets , 2005, Cell.

[18]  J. Massagué,et al.  Cancer Metastasis: Building a Framework , 2006, Cell.

[19]  N. Artzi,et al.  Implantable hydrogel embedded dark-gold nanoswitch as a theranostic probe to sense and overcome cancer multidrug resistance , 2015, Proceedings of the National Academy of Sciences.

[20]  Tatjana Crnogorac-Jurcevic,et al.  Palladin Mutation Causes Familial Pancreatic Cancer and Suggests a New Cancer Mechanism , 2006, PLoS medicine.

[21]  Elazer R. Edelman,et al.  Regulation of dendrimer/dextran material performance by altered tissue microenvironment in inflammation and neoplasia , 2015, Science Translational Medicine.

[22]  I. Macdonald,et al.  Metastasis: Dissemination and growth of cancer cells in metastatic sites , 2002, Nature Reviews Cancer.

[23]  H. J. Kim,et al.  Palladin promotes invasion of pancreatic cancer cells by enhancing invadopodia formation in cancer-associated fibroblasts , 2014, Oncogene.

[24]  P. A. van den Brandt,et al.  A Let-7 MicroRNA SNP in the KRAS 3′UTR Is Prognostic in Early-Stage Colorectal Cancer , 2011, Clinical Cancer Research.

[25]  M. Griswold,et al.  Peptide targeted tripod macrocyclic Gd(III) chelates for cancer molecular MRI. , 2013, Biomaterials.

[26]  Hong-Jin Kim,et al.  Palladin expression is a conserved characteristic of the desmoplastic tumor microenvironment and contributes to altered gene expression , 2015, Cytoskeleton.

[27]  Fei Li,et al.  Hsa-mir-182 suppresses lung tumorigenesis through down regulation of RGS17 expression in vitro. , 2010, Biochemical and biophysical research communications.

[28]  I. Fidler,et al.  The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited , 2003, Nature Reviews Cancer.

[29]  J. Conde,et al.  Effect of PEG biofunctional spacers and TAT peptide on dsRNA loading on gold nanoparticles , 2012, Journal of Nanoparticle Research.

[30]  H. Prentice-Dunn,et al.  Palladin Contributes to Invasive Motility in Human Breast Cancer Cells , 2008, Oncogene.

[31]  A. Jemal,et al.  Cancer statistics, 2015 , 2015, CA: a cancer journal for clinicians.

[32]  Libing Song,et al.  Unregulated miR-96 Induces Cell Proliferation in Human Breast Cancer by Downregulating Transcriptional Factor FOXO3a , 2010, PloS one.

[33]  K. Hunter,et al.  Murine mammary carcinoma 4T1 induces a leukemoid reaction with splenomegaly: association with tumor-derived growth factors. , 2007, Experimental and molecular pathology.

[34]  N. Artzi,et al.  Hydrogel Doped with Nanoparticles for Local Sustained Release of siRNA in Breast Cancer , 2015, Advanced healthcare materials.

[35]  George Poste,et al.  The "seed and soil" hypothesis revisited. , 2008, The Lancet. Oncology.

[36]  miR-96 suppresses renal cell carcinoma invasion via downregulation of Ezrin expression , 2015, Journal of experimental & clinical cancer research : CR.

[37]  W. Gauderman.  Candidate gene association analysis for a quantitative trait, using parent‐offspring trios , 2003, Genetic epidemiology.

[38]  M. El-Sibai,et al.  Palladin regulation of the actin structures needed for cancer invasion , 2014, Cell adhesion & migration.

[39]  J. Conde,et al.  Design of multifunctional gold nanoparticles for in vitro and in vivo gene silencing. , 2012, ACS nano.

[40]  Hui Zhang,et al.  MiR-183/-96/-182 cluster is up-regulated in most breast cancers and increases cell proliferation and migration , 2014, Breast Cancer Research.

[41]  G. Weber.  Why does cancer therapy lack effective anti-metastasis drugs? , 2013, Cancer letters.

[42]  Jing Wang,et al.  The miR-200 family and the miR-183~96~182 cluster target Foxf2 to inhibit invasion and metastasis in lung cancers , 2015, Oncogene.

[43]  Elspeth A. Bruford,et al.  Genenames.org: the HGNC resources in 2015 , 2014, Nucleic Acids Res..

[44]  Robert Gentleman,et al.  Software for Computing and Annotating Genomic Ranges , 2013, PLoS Comput. Biol..

[45]  G. Owens,et al.  The Actin Associated Protein Palladin Is Important for the Early Smooth Muscle Cell Differentiation , 2010, PloS one.

[46]  Zhangsuo Liu,et al.  miR-96 downregulates RECK to promote growth and motility of non-small cell lung cancer cells , 2014, Molecular and Cellular Biochemistry.

[47]  Hung-Ming Wang,et al.  An open-labeled phase II trial of docetaxel in combination with cisplatin as first-line cytotoxic therapy for anthracycline-naive patients with metastatic breast cancer , 2007, Anti-cancer drugs.

[48]  D. Polsky,et al.  Aberrant miR-182 expression promotes melanoma metastasis by repressing FOXO3 and microphthalmia-associated transcription factor , 2009, Proceedings of the National Academy of Sciences.

[49]  Xuan Huang,et al.  miR‑96 functions as a tumor suppressor gene by targeting NUAK1 in pancreatic cancer. , 2014, International journal of molecular medicine.

[50]  Christophe Ampe,et al.  The actin cytoskeleton in normal and pathological cell motility. , 2004, The international journal of biochemistry & cell biology.

[51]  B. White,et al.  Coordinate Regulation of FOXO1 by miR-27a, miR-96, and miR-182 in Breast Cancer Cells , 2009, The Journal of Biological Chemistry.

[52]  Elspeth A. Bruford,et al.  Genenames.org: the HGNC resources in 2013 , 2012, Nucleic Acids Res..

[53]  Li Jin.  The actin associated protein palladin in smooth muscle and in the development of diseases of the cardiovasculature and in cancer , 2011, Journal of Muscle Research and Cell Motility.

[54]  Aleix Prat Aparicio.  Comprehensive molecular portraits of human breast tumours , 2012 .

[55]  G. Koumakis,et al.  Vinorelbine and Cisplatin for Metastatic Breast Cancer: A Salvage Regimen in Patients Progressing After Docetaxel and Anthracycline Treatment , 2003, Cancer investigation.

[56]  Hyun Seok Song,et al.  Self-assembled RNA-triple-helix hydrogel scaffold for microRNA modulation in the tumour microenvironment. , 2016, Nature materials.

[57]  Guangchuang Yu,et al.  clusterProfiler: an R package for comparing biological themes among gene clusters. , 2012, Omics : a journal of integrative biology.

[58]  Jia Yu,et al.  miRNA-96 suppresses KRAS and functions as a tumor suppressor gene in pancreatic cancer. , 2010, Cancer research.

[59]  Lin Fang,et al.  miR-96 promotes tumor proliferation and invasion by targeting RECK in breast cancer. , 2014, Oncology reports.

[60]  M. Zhong,et al.  MTSS1 gene regulated by miR-96 inhibits cell proliferation and metastasis in tongue squamous cellular carcinoma Tca8113 cell line. , 2015, International journal of clinical and experimental medicine.

[61]  J. Peterse,et al.  Breast cancer metastasis: markers and models , 2005, Nature Reviews Cancer.

[62]  Steven J. M. Jones,et al.  Comprehensive molecular portraits of human breast tumors , 2012, Nature.

[63]  Peifang Liu,et al.  Functional SNP in the microRNA-367 binding site in the 3′UTR of the calcium channel ryanodine receptor gene 3 (RYR3) affects breast cancer risk and calcification , 2011, Proceedings of the National Academy of Sciences.

[64]  F. André,et al.  Optimal strategies for the treatment of metastatic triple-negative breast cancer with currently approved agents. , 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

[65]  F. Miller,et al.  Selective events in the metastatic process defined by analysis of the sequential dissemination of subpopulations of a mouse mammary tumor. , 1992, Cancer research.